| # | Title | Journal | Year | Citations |
|---|
| 1 | Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer | JAMA - Journal of the American Medical Association | 2006 | 833 |
| 2 | Erectile Dysfunction and Subsequent Cardiovascular Disease | JAMA - Journal of the American Medical Association | 2005 | 761 |
| 3 | Operating Characteristics of Prostate-Specific Antigen in Men With an Initial PSA Level of 3.0 ng/mL or Lower | JAMA - Journal of the American Medical Association | 2005 | 586 |
| 4 | Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial | Lancet, The | 2018 | 537 |
| 5 | Effect of Finasteride on the Sensitivity of PSA for Detecting Prostate Cancer | Journal of the National Cancer Institute | 2006 | 292 |
| 6 | Perioperative Outcomes and Oncologic Efficacy from a Pilot Prospective Randomized Clinical Trial of Open Versus Robotic Assisted Radical Cystectomy | Journal of Urology | 2013 | 248 |
| 7 | Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations | European Urology | 2009 | 247 |
| 8 | ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males | International Journal of Impotence Research | 2009 | 232 |
| 9 | Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations | Journal of Andrology | 2009 | 229 |
| 10 | l-2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer | Cancer Discovery | 2014 | 226 |
| 11 | Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer | Urology | 2014 | 193 |
| 12 | Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial | Lancet Oncology, The | 2021 | 172 |
| 13 | ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males | Aging Male | 2009 | 160 |
| 14 | Elevated snoRNA biogenesis is essential in breast cancer | Oncogene | 2014 | 155 |
| 15 | NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance | Nature Communications | 2017 | 147 |
| 16 | Investigation, treatment and monitoring of late‐onset hypogonadism in males | Journal of Developmental and Physical Disabilities | 2009 | 138 |
| 17 | A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies | Journal of Nuclear Medicine | 2018 | 124 |
| 18 | CD44 Expression Level and Isoform Contributes to Pancreatic Cancer Cell Plasticity, Invasiveness, and Response to Therapy | Clinical Cancer Research | 2016 | 117 |
| 19 | Prostate-specific antigen in the early detection of prostate cancer | Cmaj | 2007 | 107 |
| 20 | Associations of demographic and lifestyle characteristics with prostate‐specific antigen (PSA) concentration and rate of PSA increase | Cancer | 2006 | 106 |
| 21 | Urodynamic Effects of Once Daily Tadalafil in Men With Lower Urinary Tract Symptoms Secondary to Clinical Benign Prostatic Hyperplasia: A Randomized, Placebo Controlled 12-Week Clinical Trial | Journal of Urology | 2010 | 102 |
| 22 | [-2]Proenzyme Prostate Specific Antigen for Prostate Cancer Detection: A National Cancer Institute Early Detection Research Network Validation Study | Journal of Urology | 2008 | 98 |
| 23 | Finasteride Improves the Sensitivity of Digital Rectal Examination for Prostate Cancer Detection | Journal of Urology | 2007 | 94 |
| 24 | Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis | International Journal of Radiation Oncology Biology Physics | 2017 | 93 |
| 25 | A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts | European Urology | 2018 | 93 |
| 26 | Is a 1-cm margin necessary during nephron-sparing surgery for renal cell carcinoma? | Urology | 2001 | 91 |
| 27 | Akt/cAMP-Responsive Element Binding Protein/Cyclin D1 Network: A Novel Target for Prostate Cancer Inhibition in Transgenic Adenocarcinoma of Mouse Prostate Model Mediated by Nexrutine, a Phellodendron Amurense Bark Extract | Clinical Cancer Research | 2007 | 91 |
| 28 | Screening for Prostate Cancer | Ca-A Cancer Journal for Clinicians | 2009 | 90 |
| 29 | High Costs of Urinary Incontinence Among Women Electing Surgery to Treat Stress Incontinence | Obstetrics and Gynecology | 2008 | 89 |
| 30 | Prediction of Prostate Cancer for Patients Receiving Finasteride: Results From the Prostate Cancer Prevention Trial | Journal of Clinical Oncology | 2007 | 85 |
| 31 | Health‐related quality of life from a prospective randomised clinical trial of robot‐assisted laparoscopic vs open radical cystectomy | BJU International | 2014 | 81 |
| 32 | Chemoprevention of Prostate Cancer | Journal of Urology | 2009 | 80 |
| 33 | Inhibition of PI3K/AKT/mTOR axis disrupts oxidative stress-mediated survival of melanoma cells | Oncotarget | 2015 | 79 |
| 34 | Biomarkers for Prostate Cancer Detection | Journal of Urology | 2007 | 75 |
| 35 | Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup | Journal of Urology | 2020 | 75 |
| 36 | Genetic pattern of prostate cancer progression | | 1999 | 70 |
| 37 | microRNA-21 Governs TORC1 Activation in Renal Cancer Cell Proliferation and Invasion | PLoS ONE | 2012 | 70 |
| 38 | Vitamin E: A dark horse at the crossroad of cancer management | Biochemical Pharmacology | 2013 | 70 |
| 39 | Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group | World Journal of Urology | 2012 | 66 |
| 40 | Screening for Bladder Cancer: Rationale, Limitations, Whom to Target, and Perspectives | European Urology | 2013 | 64 |
| 41 | Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy? | Cell Death and Disease | 2014 | 60 |
| 42 | Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial | Prostate | 2016 | 60 |
| 43 | Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry | Journal of the National Cancer Institute | 2017 | 57 |
| 44 | Hypospadias: a contemporary epidemiologic assessment | Urology | 2001 | 56 |
| 45 | A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer | Prostate | 2015 | 55 |
| 46 | Insulin‐like growth factor‐I, insulin‐like growth factor binding protein‐3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial | Prostate | 2008 | 54 |
| 47 | Antioxidants for prostate cancer chemoprevention: Challenges and opportunities | Biochemical Pharmacology | 2012 | 54 |
| 48 | Correlating mammographic and pathologic findings in clinical decision support using natural language processing and data mining methods | Cancer | 2017 | 54 |
| 49 | Finasteride Decreases the Risk of Prostatic Intraepithelial Neoplasia | Journal of Urology | 2007 | 52 |
| 50 | Prostate MRI: Access to and Current Practice of Prostate MRI in the United States | Journal of the American College of Radiology | 2014 | 52 |
